nVerses Capital’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$160K Sell
25,234
-15,312
-38% -$75.1K 0.25% 210
2026
Q1
$139K Buy
+40,546
New +$137K 0.13% 310
2024
Q4
Sell
-5,800
Closed -$161K 75
2024
Q3
$161K Buy
5,800
+1,800
+45% +$45K 0.07% 379
2024
Q2
$95.4K Buy
+4,000
New +$93.9K 0.06% 453

Other funds holding ASPN

nVerses Capital's ASPN Position: Q2 2026 in Review

nVerses Capital reduced its Aspen Aerogels (ASPN) stake by 38% in Q2 2026, selling an estimated $75.1K and leaving 25,234 shares worth $160K. The position accounts for 0.25% of the portfolio, ranked #210.

nVerses Capital first reported a position in ASPN in Q2 2024 and has held it in 4 quarters since. The position peaked at $161K in Q3 2024. 130 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • nVerses Capital held 25,234 shares of Aspen Aerogels worth $160K as of Q2 2026.
  • nVerses Capital sold 15,312 Aspen Aerogels shares in Q2 2026, an estimated $75.1K.
  • Aspen Aerogels made up 0.25% of nVerses Capital's portfolio in Q2 2026, its #210 holding.
  • nVerses Capital first reported a position in Aspen Aerogels in Q2 2024 and has held it in 4 quarters since.
  • nVerses Capital's Aspen Aerogels position peaked at $161K in Q3 2024.
  • 130 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.